Cargando…
Computational drug repurposing for inflammatory bowel disease using genetic information
As knowledge of the genetics behind inflammatory bowel disease (IBD) has continually improved, there has been a demand for methods that can use this data in a clinically significant way. Genome-wide association analyses for IBD have identified 232 risk genetic loci for the disorder. While identifica...
Autores principales: | Grenier, Liam, Hu, Pingzhao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352300/ https://www.ncbi.nlm.nih.gov/pubmed/30728920 http://dx.doi.org/10.1016/j.csbj.2019.01.001 |
Ejemplares similares
-
Computational Drug Repurposing for Alzheimer’s Disease Using Risk Genes From GWAS and Single-Cell RNA Sequencing Studies
por: Xu, Yun, et al.
Publicado: (2021) -
A Maximum Flow-Based Approach to Prioritize Drugs for Drug Repurposing of Chronic Diseases
por: Islam, Md. Mohaiminul, et al.
Publicado: (2021) -
Repurposing a Drug Targeting Inflammatory Bowel Disease for Lowering Hypertension
por: Mei, Xue, et al.
Publicado: (2022) -
Association Between a Multi-Locus Genetic Risk Score and Inflammatory Bowel Disease
por: Hu, Pingzhao, et al.
Publicado: (2013) -
Network controllability solutions for computational drug repurposing using genetic algorithms
por: Popescu, Victor-Bogdan, et al.
Publicado: (2022)